Study: RWD not ready for postapproval prime time
Regulatory NewsKari Oakes
Biologics/ biosimilars/ vaccinesClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsKari OakesBiologics/ biosimilars/ vaccinesClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy